Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CreAgri was a California-based nutraceutical and functional-ingredients company focused on olive-derived polyphenols, especially hydroxytyrosol. The company developed patented processes to recover and concentrate antioxidant compounds from organic olives and commercialized these ingredients under the HIDROX brand. Its products were positioned for use in dietary supplements, foods, beverages, cosmetics, and skin-care products, with marketing centered on antioxidant activity and LDL protection claims. Available company-profile sources indicate CreAgri raised venture financing but later ceased operations. The business appears to have operated at the intersection of nutrition, wellness, and natural-product technology rather than as a traditional therapeutic biotech developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CreAgri.